We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-20 of 10,000 results
  1. The Association of Gabapentin Initiation with Cognitive and Behavioral Changes in Older Adults with Cognitive Impairment: A Retrospective Cohort Study

    Background

    Although gabapentin has been increasingly prescribed to older adults, the relation between gabapentin initiation and longer-term...

    GYeon Oh, Daniela C. Moga, ... Erin L. Abner in Drugs & Aging
    Article 09 July 2024
  2. Use of Muscle Relaxants After Surgery in Traditional Medicare Part D Enrollees

    Background

    Surgeons have come under increased scrutiny for postoperative pain management, particularly for opioid prescribing. To decrease opioid use...

    Tasce Bongiovanni, Siqi Gan, ... Michael A. Steinman in Drugs & Aging
    Article Open access 09 July 2024
  3. Lichen Planus: What is New in Diagnosis and Treatment?

    Lichen planus (LP), an idiopathic, multifaceted chronic inflammatory disease with a heterogeneous clinical presentation, affects approximately 0.5–1%...

    Burak Tekin, Fangyi **e, Julia S. Lehman in American Journal of Clinical Dermatology
    Article 09 July 2024
  4. Pre-clinical Models for Geriatric Pharmacotherapy

    With ageing of the population worldwide and discovery of new medications for prevention and management of age-related conditions, there is increasing...

    Sarah N. Hilmer, Kristina Johnell, John Mach in Drugs & Aging
    Article Open access 09 July 2024
  5. DNA methylation profiles of cancer-related fatigue associated with markers of inflammation and immunometabolism

    Cancer patients are commonly affected by fatigue. Herein, we sought to examine epigenetic modifications (i.e., DNA methylation) related to fatigue in...

    Canhua **ao, Gang Peng, ... Andrew H. Miller in Molecular Psychiatry
    Article 09 July 2024
  6. Serum dysregulation of serine and glycine metabolism as predictive biomarker for cognitive decline in frail elderly subjects

    Frailty is a common age-related clinical syndrome characterized by a decline in the function of multiple organ systems, increased vulnerability to...

    Alberto Imarisio, Isar Yahyavi, ... Enza Maria Valente in Translational Psychiatry
    Article Open access 09 July 2024
  7. Modulation of dlPFC function and decision-making capacity by repetitive transcranial magnetic stimulation in methamphetamine use disorder

    This study explores the impact of repetitive transcranial magnetic stimulation (rTMS) on decision-making capabilities in individuals with...

    Qingming Liu, Huimin Cui, ... Hui Zheng in Translational Psychiatry
    Article Open access 08 July 2024
  8. The Use of Drugs that Should be Avoided or Used with Caution in Patients Hospitalized for Acute Decompensated Heart Failure

    Background

    Heart failure (HF) is a pervasive global health concern, with acute decompensated heart failure (ADHF) contributing significantly to...

    Article 08 July 2024
  9. Effect of transcranial direct current stimulation with concurrent cognitive performance targeting posterior parietal cortex vs prefrontal cortex on working memory in schizophrenia: a randomized clinical trial

    Working memory deficits are linked to irregularities in the dorsolateral prefrontal cortex (DLPFC) and the posterior parietal cortex (PPC) in...

    Wenpeng Hou, Fuchun Zhou, ... Chuanyue Wang in Translational Psychiatry
    Article Open access 08 July 2024
  10. The risks for major psychiatric disorders in the siblings of probands with major depressive disorder

    Using a case-controlled study including siblings of major depression (MD) and control probands, born 1970–1990 and followed through 2018, we sought...

    Sang ** Rhee, Linda Abrahamsson, ... Kenneth S. Kendler in Molecular Psychiatry
    Article Open access 07 July 2024
  11. Thalamocortical functional connectivity and rapid antidepressant and antisuicidal effects of low-dose ketamine infusion among patients with treatment-resistant depression

    Previous studies have shown an association between the thalamocortical dysconnectivity and treatment-resistant depression (TRD). Whether a single...

    Pei-Chi Tu, Wan-Chen Chang, ... Mu-Hong Chen in Molecular Psychiatry
    Article Open access 06 July 2024
  12. Pharmacotherapy as an Augmentation to Bariatric Surgery for Obesity

    A global obesity pandemic is one of the most significant health threats worldwide owing to its close association with numerous comorbidities such as...

    Luděk Horváth, Miloš Mráz, ... Martin Haluzík in Drugs
    Article Open access 06 July 2024
  13. Effects of psychedelic, DOI, on nucleus accumbens dopamine signaling to predictable rewards and cues in rats

    Psychedelics produce lasting therapeutic responses in neuropsychiatric diseases suggesting they may disrupt entrenched associations and catalyze...

    David A. Martin, Angel M. Delgado, Donna J. Calu in Neuropsychopharmacology
    Article 06 July 2024
  14. Nogapendekin alfa Inbakicept: First Approval

    Nogapendekin alfa inbakicept (ANKTIVA ® ; nogapendekin alfa inbakicept-pmln) is a recombinant interleukin-15 (IL-15) superagonist protein complex being...

    Susan J. Keam in Drugs
    Article 05 July 2024
  15. Givinostat: First Approval

    Givinostat (DUVYZAT™), an orally available histone deacetylase inhibitor, is being developed by Italfarmaco for the treatment of muscular dystrophy...

    Yvette N. Lamb in Drugs
    Article 05 July 2024
  16. Empagliflozin Effects in Patients with ST-Elevation Myocardial Infarction Undergoing Primary PCI: The EMI-STEMI Randomized Clinical Trial

    Introduction

    Empagliflozin, a sodium-glucose cotransporter 2 (SGLT2) inhibitor, improves cardiovascular outcomes in heart failure patients, but data...

    Elnaz Khani, Naser Aslanabadi, ... Taher Entezari-Maleki in American Journal of Cardiovascular Drugs
    Article 05 July 2024
  17. Investigating the Bioavailability and Insulin-like Growth Factor-I Release of Two Different Strengths of Somapacitan: A Randomised, Double-Blind Crossover Trial

    Study Design and Objective

    Randomised, double-blind, crossover trial to confirm bioequivalence of somapacitan, a long-acting growth hormone (GH), in...

    Sarah Louise Dombernowsky, Birgitte Bentz Damholt, ... Rasmus Juul Kildemoes in Clinical Pharmacokinetics
    Article Open access 05 July 2024
  18. Serotonergic psychedelic 5-MeO-DMT alters plasticity-related gene expression and generates anxiolytic effects in stressed mice

    Serotonergic psychedelics have potential therapeutic effects in treating anxiety and mood disorders, often after a single dose, and are suggested to...

    Margareth Nogueira, Daiane C. Ferreira Golbert, ... Richardson N. Leão in Molecular Psychiatry
    Article 05 July 2024
  19. Comparative CNS Pharmacology of the Bruton’s Tyrosine Kinase (BTK) Inhibitor Tolebrutinib Versus Other BTK Inhibitor Candidates for Treating Multiple Sclerosis

    Background and objectives

    Tolebrutinib is a covalent BTK inhibitor designed and selected for potency and CNS exposure to optimize impact on...

    Timothy J. Turner, Pricilla Brun, ... Dimitry Ofengeim in Drugs in R&D
    Article Open access 05 July 2024
Did you find what you were looking for? Share feedback.